IART · NASDAQ
Integra LifeSciences Holdings Corporation
$12.10 +0.19 (+1.60%)
Company overview
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments: Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment, as well as surgical headlamps and instrumentation, asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $941M
- Employees
- 4,396
- Headquarters
- Princeton, NJ
- Website
- integralife.com
- CEO
- Mojdeh Poul
- Listed
- August 16, 1995
- P/E
- -1.87
- Dividend yield
- 0.00%
Company financials
- Revenue
- $1.6B
- Gross profit
- $875M
- Operating income
- $124M
- EBITDA
- -$274M
- Net income
- -$496M
- EPS
- -$6.48
- Total assets
- $3.6B
- Total debt
- $2B
- Gross margin
- 53.21%
- Net margin
- -30.15%
- Earnings yield
- -53.57%
Showing FY 2025
IART
1D
NASDAQ
O12.12H12.40L11.82C11.91-0.41 (-3.37%)Vol1.21M